The REFER (REFer for EchocaRdiogram) protocol: a prospective validation of a clinical decision rule, NT-proBNP, or their combination, in the diagnosis of heart failure in primary care. Rationale and design

BMC Cardiovascular Disorders

FD Richard Hobbs³  Marites Derit⁶  Clare J Taylor⁶  Pelham M Barton²  Rachel Iles⁶  Jonathan J Deeks⁵  Martin R Cowie¹  Jonathan Mant⁴  Andrea K Roalfe⁶  Lynda Tait⁶ 

[1] Imperial College London (Royal Brompton Hospital), London, SW3 6LY, UK;Health Economics Unit, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK;Department of General Practice, University of Oxford, 23-38 Hythe Bridge Street, Oxford, OX1 2ET, UK;General Practice & Primary Care Research Unit, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 OSR, UK;Public Health, Epidemiology and Biostatistics, Public Health Building, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK;Primary Care Clinical Sciences, Primary Care Clinical Sciences Building, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK

关键词: NT-proBNP;    Echocardiogram;    Diagnosis;    Clinical decision rule;    Heart failure;   

Others  :  858018
DOI  :  10.1186/1471-2261-12-97

 received in 2012-09-25, accepted in 2012-10-17,  发布年份 2012

【 摘 要 】

Background

Heart failure is a major cause of mortality and morbidity. As mortality rates are high, it is important that patients seen by general practitioners with symptoms suggestive of heart failure are identified quickly and treated appropriately. Identifying patients with heart failure or deciding which patients need further tests is a challenge. All patients with suspected heart failure should be diagnosed using objective tests such as echocardiography, but it is expensive, often delayed, and limited by the significant skill shortage of trained echocardiographers. Alternative approaches for diagnosing heart failure are currently limited. Clinical decision tools that combine clinical signs, symptoms or patient characteristics are designed to be used to support clinical decision-making and validated according to strict methodological procedures. The REFER Study aims to determine the accuracy and cost-effectiveness of our previously derived novel, simple clinical decision rule, a natriuretic peptide assay, or their combination, in the triage for referral for echocardiography of symptomatic adult patients who present in general practice with symptoms suggestive of heart failure.

Methods/design

This is a prospective, Phase II observational, diagnostic validation study of a clinical decision rule, natriuretic peptides or their combination, for diagnosing heart failure in primary care. Consecutive adult primary care patients 55 years of age or over presenting to their general practitioner with a chief complaint of recent new onset shortness of breath, lethargy or peripheral ankle oedema of over 48 hours duration, with no obvious recurrent, acute or self-limiting cause will be enrolled. Our reference standard is based upon a three step expert specialist consensus using echocardiography and clinical variables and tests.

Discussion

Our clinical decision rule offers a potential solution to the diagnostic challenge of providing a timely and accurate diagnosis of heart failure in primary care. Study results will provide an evidence-base from which to develop heart failure care pathway recommendations and may be useful in standardising care. If demonstrated to be effective, the clinical decision rule will be of interest to researchers, policy makers and general practitioners worldwide.

Trial registration

ISRCTN17635379

【 授权许可】

   
2012 Tait et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Task FM, McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Böhm M, et al.: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J 2012, 33:1787-1847.
• [2]Davies MK, Hobbs FDR, Davis RC, Kenkre JE, Roalfe AK, Hare R, et al.: Prevalence of left-ventricular systolic dysfunction and heart failure in the echocardiographic heart of England screening study: a population based study. Lancet 2001, 358:439-444.
• [3]Hobbs FDR, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK: Impact of heart failure and left ventricular systolic dysfunction on quality of life. A cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J 2002, 23:1867-1876.
• [4]Gillum RF: Heart and stroke facts. Am Heart J 1993, 126:1042-1047.
• [5]Stewart S, Jenkins A, Buchan S, McGuire A, Capewell S, McMurray JJJV: The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail 2002, 4:361-371.
• [6]Fuat A, Hungin AP, Murphy JJ: Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ 2003, 326:196.
• [7]Khunti K, Hearnshaw H, Baker R, Grimshaw G: Heart failure in primary care: qualitative study of current management and perceived obstacles to evidence-based diagnosis and management by general practitioners. Eur J Heart Fail 2002, 4:771-777.
• [8]Remes J, MlEttinen H, Reunanen A, Pyorala K: Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991, 12:315-321.
• [9]Skaner Y, Bring J, Ullman B, Strender LE: Heart failure diagnosis in primary health care: clinical characteristics of problematic patients. A clinical judgement analysis study. BMC Fam Pract 2003, 4:12. BioMed Central Full Text
• [10]Garg R, Yusuf S: Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 1995, 273:1450-1456.
• [11]CIBIS-II Investigators and Committees: The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet 1999, 353:9-13.
• [12]Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al.: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999, 341:709-717.
• [13]Hobbs FDR: Unmet need for diagnosis of heart failure: the view from primary care. Heart 2002, 88:ii9-ii11.
• [14]The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 2008, 29:2388-2442.
• [15]Zannad F, McMurray JJV, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, et al.: Eplerenone in patients with systolic heart failure and mild symptoms. N Eng J Med 2010, 364:11-21.
• [16]NICE: Chronic heart failure: national clinical guideline for diagnosis and management in primary and secondary care. Full version of NICE Guideline No. 5. London: Royal College of Physicians; 2003.
• [17]NICE: Chronic heart failure: management of chronic heart failure in adults in primary and secondary care (partial update). London: Royal College of Physicians; 2010.
• [18]Hobbs FDR, Jones MI, Allan TF, Wilson S, Tobias R: European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF). Eur Heart J 2000, 21:1877-1887.
• [19]Hickling JA, Nazareth I, Rogers S: The barriers to effective management of heart failure in general practice. Br J Gen Pract 2001, 51:615-618.
• [20]Remme WJ, McMurray JJV, Hobbs FDR, Cohen-Solal A, Lopez-Sendon J, Boccanelli A, et al.: Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians. Eur Heart J 2008, 29:1739-1752.
• [21]Remme WJ, Swedberg K: Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001, 22:1527-1560.
• [22]Madhok V, Falk G, Rogers A, Struthers AD, Sullivan FM, Fahey T: The accuracy of symptoms, signs and diagnostic tests in the diagnosis of left ventricular dysfunction in primary care: a diagnostic accuracy systematic review. BMC Fam Pract 2008, 9:56. BioMed Central Full Text
• [23]Badgett RG, Mulrow CD, Otto P, Ramirez G: How well can the chest radiograph diagnose left ventricular dysfunction? J Gen Intern Med 1996, 11:625-634.
• [24]Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA: Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997, 350:1349-1353.
• [25]Cowie MR, Jourdain P, Maisel A, Dahlstrom U, Follath F, Isnard R, et al.: Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 2003, 24:1710-1718.
• [26]Hobbs FDR, Davis RC, Roalfe AK, Hare R, Davies MK: Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations. Heart 2004, 90:866-870.
• [27]Hobbs FDR, Davis RC, Roalfe AK, Hare R, Davies MK, Kenkre JE: Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ 2002, 324:1498-1500.
• [28]Wright SP, Doughty RN, Pearl A, Gamble GD, Whalley GA, Walsh HJ, et al.: Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial. J Am Coll Cardiol 2003, 42:1793-1800.
• [29]Mueller T, Gegenhuber A, Poelz W, Haltmayer M: Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart 2005, 91:606-612.
• [30]Januzzi J, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, et al.: The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005, 95:948-954.
• [31]Wang CS, FitzGerald JM, Schulzer M, Mak E, Ayas NT: Does this dyspneic patient in the emergency department have congestive heart failure? JAMA 2005, 294:1944-1956.
• [32]Zaphiriou A, Robb S, Murray-Thomas T, Mendez G, Fox K, McDonagh T, et al.: The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study. Eur J Heart Fail 2005, 7:537-541.
• [33]Fuat A, Murphy JJ, Hungin AP, Curry J, Mehrzad AA, Hetherington A: The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure. Br J Gen Pract 2006, 56:327-333.
• [34]Battaglia M, Pewsner D, Juni P, Egger M, Bucher HC, Bachmann LM: Accuracy of B-type natriuretic peptide tests to exclude congestive heart failure: systematic review of test accuracy studies. Arch Intern Med 2006, 166:1073-1080.
• [35]McGinn TG, Guyatt GH, Wyer PC, Naylor CD, Stiell IG, Richardson WS, et al.: Users’ guides to the medical literature: XXII: how to use articles about clinical decision rules. JAMA 2000, 284:79-84.
• [36]Stiell IG, Wells GA: Methodological standards for the development of clinical decision rules in emergency medicine. Ann Emerg Med 1999, 33:437-447.
• [37]Mosaterd A, Deckers JW, Hoes AW, Nederpel A, Smeets A, Linker DT, et al.: Classification of heart failure in population based research: an assessment of six heart failure scores. Eur J Epidemiol 1997, 13:491-502.
• [38]Baggish AL, Siebert U, Lainchbury JG, Cameron R, Anwaruddin S, Chen A, et al.: A validated clinical and biochemical score for the diagnosis of acute heart failure: the ProBNP investigation of dyspnea in the emergency department (PRIDE) acute heart failure score. Am Heart J 2006, 151:48-54.
• [39]Fahey T, Jeyaseelan S, McCowan C, Carr E, Goudie B, Pringle S: Diagnosis of left ventricular systolic dysfunction (LVSD): development and validation of a clinical prediction rule in primary care. Fam Pract 2007, 24:628-635.
• [40]Mant J, Doust J, Roalfe AK, Barton P, Cowie MR, Glasziou P, et al.: Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technol Assess 2009, 13(32):1-232.
• [41]Roalfe AK, Mant J, Doust JA, Barton P, Cowie MR, Glasziou P, et al.: Development and initial validation of a simple clinical decision tool to predict the presence of heart failure in primary care: the MICE (Male, Infarction, Crepitations, Edema) rule. Eur J Heart Fail 2012, 14:1000-1008.
• [42]Barksfield R: Diagnosing heart failure in primary care. The role of clinical features and BNP: a multicentre UK diagnostic study. BSc dissertation. Imperial College London; 2005.
• [43]Bossuyt PM, Irwig L, Craig J, Glasziou P: Comparative accuracy: assessing new tests against existing diagnostic pathways. BMJ 2006, 332:1089-1092.
• [44]Group EQ: EuroQol - a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990, 16:199-208.
• [45]Ware J, Kosinski M, Keller SD: A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Medical Care 1996, 34:220-233.
• [46]Muller-Nordhorn J, Roll S, Willich SN: Comparison of the short form (SF)-12 health status instrument with the SF-36 in patients with coronary heart disease. Heart 2004, 90:523-527.
• [47]Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure: ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 2008, 29:2388-2442.
• [48]Briggs A, Claxton K, Sculpher M: Decision Modelling for Health Economic Evaluation. Oxford: Oxford University Press; 2006.
• [49]Curtis L: Unit Costs of Health and Social Care. Kent: Canterbury: Personal Social Services Research Unit, University of Kent at Canterbury; 2007.
• [50]Department of Health: NHS reference costs 2007–08. London: Department of Health; 2009.
• [51]National Institute for Health and Clinical Excellence: Updated guide to the methods of technology appraisal - June 2008. London: National Institute for Health and Clinical Excellence; 2008.
• [52]Sutton AJ, Cooper NJ, Goodacre S, Stevenson M: Integration of meta-analysis and economic decision modeling for evaluating diagnostic tests. Medical Decision Making 2008, 28:650-667.
• [53]Wheeldon NM, MacDonald TM, Flucker CJ, McKendrick AD, McDevitt DG, Struthers AD: Echocardiography in chronic heart failure in the community. Quarterly J Med 1993, 86:17-20.
• [54]Laupacis A, Sekar N, Stiell IG: Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA 1997, 277:488-494.
• [55]Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al.: Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin Chem 2003, 49:1-6.
• [56]Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al.: The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem 2003, 49:7-18.
• [57]Whiting P, Rutjes AWS, Reitsma JB, Glas AS, Bossuyt PMM: Sources of variation and bias in studies of diagnostic accuracy. Arch Intern Med 2004, 140:189-202.
• [58]Rutjes AWS, Reitsma JB, Di Nisio M, Smidt N, van Rijn JC, Bossuyt PMM: Evidence of bias and variation in diagnostic accuracy studies. Can Med Assoc J 2006, 174:469-476.
• [59]Irwig L, Bossuyt P, Glasziou P, Gatsonis C, Lijmer J: Evidence base of clinical diagnosis: designing studies to ensure that estimates of test accuracy are transferable. BMJ 2002, 324:669-671.